Cargando…
Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis
AIM: This retrospective study aimed to evaluate the predictive value of serum cancer antigen 125 (CA125) levels before hormone replacement therapy on pregnancy outcomes in women with adenomyosis undergoing frozen embryo transfer. METHODS: A total of 509 women with adenomyosis were screened and 84 pa...
Autores principales: | Huang, Ling, Li, Yubin, Chen, Minghui, Wang, Zengyan, Zhou, Canquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072100/ https://www.ncbi.nlm.nih.gov/pubmed/33887984 http://dx.doi.org/10.1177/03000605211005878 |
Ejemplares similares
-
Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Li, Muzi, et al.
Publicado: (2021) -
Effects of artificial cycles with and without gonadotropin-releasing
hormone agonist pretreatment on frozen embryo transfer outcomes
por: Qi, Qianrong, et al.
Publicado: (2020) -
Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment
por: Park, Chan Woo, et al.
Publicado: (2016) -
Effect of intrauterine perfusion of granular leukocyte-colony stimulating factor on the outcome of frozen embryo transfer
por: Zhu, Ying-Chun, et al.
Publicado: (2021) -
Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer
por: Wang, Yu, et al.
Publicado: (2023)